
To assess and report clinical outcomes after carotid sparing intensity‐modulated radiotherapy for early-stage laryngeal cancer. After a median follow‐up of 31 months, the actuarial 1‐ and 3‐year local and locoregional control rates were 99.4% and 94.7%, 98.4% and 93%, respectively. Oncologic outcomes of patients treated with carotid sparing IMRT were excellent; comparable with historical series, with acceptable side effects.
Like
Save
Share